5 Pharma Trends for 2023: Challenges and opportunities in the post-COVID landscape
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
Our products
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
As market access barriers proliferate, digitally enabled alignment is key to optimising new drug uptake.
Our Launch Readiness 2023 report examines the prospects and challenges for new medicines entering the market in the shadow of COVID-19.
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
We look at how EU drug approvals hold firm in 2022, US lags and innovation flourishes
With COVID-19 driving innovation and agility, 2022 promises another rich crop of pharma launches. Closer cost-benefit scrutiny demands carefully differentiated value.
Our 8 pharma trends for 2022 assess how new directions in the industry might lead to a more holistic conception of the value and benefit of drug innovation
US and EU drug approvals have maintained their momentum in 2021, as another innovation bounty shows the sector is finding ways to work around COVID-19.
The right launch execution software is key to optimising pharmaceutical launches through agile ways of thinking and working.
The COVID-19 pandemic is a wake-up call for pharma to embed digital transformation at every level of its operations
The COVID-19 pandemic is a wake-up call for pharma to embed digital transformation at every level of its operations
Pharma companies need a launch execution platform that makes launch excellence the norm and streamlines efforts to save time for everyone involved in product launches.
COVID-19 has intensified launch challenges facing new drugs. R&D pipelines and regulatory approvals continue to deliver innovation and commercial promise.
TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.